Scavenger receptors: Friend or foe in atherosclerosis?

Current Opinion in Lipidology

Volumn 16, Issue 5, 2005, Pages 525-535

  Van Berkel, Theo J C ^a   Out, Ruud ^a   Hoekstra, Menno ^a   Kuiper, Johan ^a   Biessen, Erik ^a   Van Eck, Miranda ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Macrophages; Scavenger receptors

Indexed keywords

ABC TRANSPORTER; ATORVASTATIN; BCG VACCINE; CD36 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NOBILETIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PHORBOL ESTER; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BI; SCAVENGER RECEPTOR C; SCAVENGER RECEPTOR CLASS A1; SCAVENGER RECEPTOR CLASS A2; SCAVENGER RECEPTOR CLASS A3; SCAVENGER RECEPTOR CLASS G; SCAVENGER RECEPTOR CLASS H; SCAVENGER RECEPTOR CLASS I; SCAVENGER RECEPTOR CLASS J; SCAVENGER RECEPTOR D; SCAVENGER RECEPTOR F; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTERY INTIMA PROLIFERATION; ARTERY WALL; ATHEROSCLEROSIS; CELL ADHESION; DRUG INHIBITION; FOAM CELL; HUMAN; MACROPHAGE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; STEROIDOGENESIS;

EID: 25444506211     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000183943.20277.26     Document Type: Review

References (102)

1. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol 1997; 8:275-280.
2. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002; 11:211-1217.
3. Geng Y, Kodama T, Hansson GK. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb 1994; 14:798-806.
4. Gough PJ, Greaves DR, Gordon S. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J Lipid Res 1998; 39:531-543.
5. Yamamoto K, Nishimura N, Doi T, et al. The lysine cluster in the collagen-like domain of the scavenger receptor provides for its ligand binding and ligand specificity. FEBS Lett 1997; 414:182-186.
6. Naito M, Suzuki H, Mori T, et al. Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 1992; 141:591-599.
7. Daugherty A, Cornicelli JA, Welch K, et al. Scavenger receptors are present on rabbit aortic endothelial cells in vivo. Arterioscler Thromb Vasc Biol 1997; 17:2369-2375.
8. Kim JG, Keshava C, Murphy AA, et al. Fresh mouse peritoneal macrophages have low scavenger receptor activity. J Lipid Res 1997; 38: 2207-2215.
9. Matsumoto A, Naito M, Itakura H, et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A 1990; 87:9133-9137.
10. Hiltunen TP, Luoma JS, Nikkari T, Yla-Herttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 1998; 97:1079-1086.
11. Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995; 95:122-133.
12. Van Lenten BJ, Fogelman AM. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. J Immunol 1992; 148: 112-116.
13. Bottalico LA, Wager RE, Agellon LB, et al. Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem 1991; 266:22866-22871.
14. Van der Kooij M, Morand OH, Kempen HJ, Van Berkel TJC. Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler Thromb Vase Biol 1996; 16:106-114.
15. Haworth R, Platt N, Keshav S, et al. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med 1997; 186:1431-1439.
16. Yoshida H, Quehenberger O, Kondratenko N, et al. Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol 1998; 18:794-802.
17. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 1989; 264:2599-2604.
18. Dunne DW, Resnick D, Greenberg JW, et al. The type I macrophage scavenger receptor binds to Gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci U S A 1994; 91:1863-1867.
19. Hampton RY, Golenbock DT, Penman M, et al. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991; 352:342-344.
20. Resnick D, Freedman NJ, Xu S, Krieger M. Secreted extracellular domains of macrophage scavenger receptors form elongated trimers which specifically bind crocidolite asbestos. J Biol Chem 1993; 268:3538-3545.
21. Elomaa O, Kangas M, Sahlberg C, et al. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995; 80:603-609.
22. Van der Laan LJW, Dopp EA, Haworth R, et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 1999; 162:939-947.
23. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994; 269:21003-21009.
24. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
25. Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995; 270:16221-16224.
26. Ji Y, Jian B, Wang N, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272:20982-20985.
27. Calvo D, Vega MA. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993; 268:18929-18935.
28. Murao K, Terpstra V, Green SR, et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997; 272: 17551-17557.
29. Webb NR, De Villiers WJS, Connell PM, et al. Alternative forms of the scavenger receptor BI (SR-BI). J Lipid Res 1997; 38:1490-1495.
30. Webb NR, Connell PM, Graf GA, et al. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 1998; 273:15241-15248.
31. Greenwalt DE, Lipsky RH, Ockenhouse CF, et al. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80:1105-1115.
32. Maeno Y, Fujioka H, Hollingdale MR, et al. Ultrastructural localization of CD36 in human hepatic sinusoidal lining cells, hepatocytes, human hepatoma (HepG2-A16) cells, and C32 amelanotic melanoma cells. Exp Parasitol 1994; 79:383-390.
33. Volpes R, Van den Oord JJ, Desmet VJ. Adhesive molecules in liver disease: immunohistochemical distribution of thrombospondin receptors in chronic HBV infection. J Hepatol 1990; 10:297-304.
34. Abrams JM, Lux A, Steller H, Krieger M. Macrophages in Drosophila embryos and L2 cells exhibit scavenger receptor-mediated endocytosis. Proc Natl Acad Sci U S A 1992; 89:10375-10379.
35. Ramprasad MP, Fischer W, Witztum JL, et al. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A 1995; 92:9580-9584.
36. Holness CL, Da SR, Fawcett J, et al. Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J Biol Chem 1993; 268:9661-9666.
37. Rabinowitz SS, Gordon S. Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med 1991; 174:827-836.
38. De Rijke YB, Van Berkel TJC. Rat liver Kupffer and endothelial cells express different binding proteins for modified low density lipoproteins: Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low density lipoproteins. J Biol Chem 1994; 269:824-827.
39. Van Velzen AG, Da Silva RP, Gordon S, Van Berkel TJC. Characterization of a receptor for oxidized low-density lipoproteins on rat Kupffer cells: similarity to macrosialin. Biochem J 1997; 322:411-415.
40. McKnight AJ, Gordon S. Membrane molecules as differentiation antigens of murine macrophages. Adv Immunol 1998; 68:271-314.
41. Van der Kooij MA, Von der Mark EM, Kruijt JK, et al. Human monocyte-derived macrophages express an approximately 120-kD Ox-LDL binding protein with strong identity to CD68. Arterioscler Thromb Vasc Biol 1997; 17:3107-3116.
42. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386:73-77.
43. Murase T, Kume N, Korenaga R, et al. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998; 83:328-333.
44. Oka K, Sawamura T, Kikuta K, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A 1998; 95:9535-9540.
45. Adachi H, Tsujimoto M, Arai H, Inoue K. Expression cloning of a novel scavenger receptor from human endothelial cells. J Biol Chem 1997; 272:31217-31220.
46. Shimaoka T, Kume N, Minami M, et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000; 275:40663-40666.
47. Matloubian M, David A, Engel S, et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1:298-304.
48. Minami M, Kume N, Shimaoka T, et al. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2001; 21:1796-1800.
49. Adachi H, Tsujimoto M. FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities. J Biol Chem 2002; 277:34264-34270.
50. Tamura Y, Adachi H, Osuga J, et al. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J Biol Chem 2003; 278:12613-12617.
51. Prevo R, Banerji S, Ni J, Jackson DG. Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1). J Biol Chem 2004; 279:52580-52590.
52. Irjala H, Alanen K, Grenman R, et al. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct binding of cancer cells to the lymph vessel endothelium. Cancer Res 2003; 63:4671-4676.
53. Salmi M, Koskinen K, Henttinen T, et al. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 2004; 104:3849-3857.
54. Madsen M, Moller HJ, Nielsen MJ, et al. Molecular characterization of the haptoglobin-hemoglobin receptor CD163: ligand binding properties of the scavenger receptor cysteine-rich domain region. J Biol Chem 2004; 279:51561-51567. CD163 is the macrophage receptor for endocytosis of haptoglobin-hemoglobin complexes and a characterization of the binding domain is provided.
55. Fadok VA, Voelker DR, Campbell PA, et al. Exposure of phosphatidyl-serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-2216.
56. Fadok VA, Bratoon DL, Rose DM, et al. A receptor for phosphatidylserine specific clearance of apoptotic cells. Nature 2004; 405:85-90.
57. Cao WK, Murao K, Imache H, et al. Phosphatidylserine receptor cooperates with high-density lipoprotein receptor in recognition of apoptotic cells by thymic nurse cells. J Mol Endocrinol 2004; 32:497-505. It appears that SR-BI and the phosphatidylserine receptor are cooperating in the recognition of apoptotic cells.
58. Kodama T, Freeman M, Rohrer L, et al. Type I macrophage scavenger-receptor contains α-helical and collagen-like coiled coils. Nature 1990; 343: 531-570.
59. Suzuki H, Kurihara Y, Takeya M, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997; 386:292-296.
60. Sakaguchi H, Takeya M, Suzuki H, et al. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab Invest 1998; 78:423-434.
61. De Winther MPJ, Gijbels MJJ, Willems van Dijk K, et al. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3 Leiden transgenic mice. Atherosclerosis 1999; 144:315-321.
62. Herijgers N, De Winther MPJ, Van Eck M, et al. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice. J Lipid Res 2000; 41:1402-1409.
63. Van Eck M, De Winther MPJ, Herijgers N, et al. Effect of human scavenger receptor class A overexpression in bone-marrow-derived cells on cholesterol levels and atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20:2600-2606.
64. Linton MF, Fazio S. Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol 2001; 12:489-495.
65. Jakanen J, Leppänen P, Pajusola K, et al. Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice. Mol Therapy 2003; 8:903-910.
66. -/- mice. As JNK2 activity is essential for SR-A phosphorylation, the SR-A is inactive in the absence of JNK2.
67. Kuronuma K, Sano H, Kato K, et al. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J Biol Chem 2004; 279:21421-21430. Casein kinase 2 activity increases the cell surface localization of SR-A.
68. Tian G, Wilcockson D, Perry H, et al. Inhibition of α-glucosidases I and II increases the cell surface expression of functional class A macrophage scavenger receptor (SR-A) by extending its half-life. J Biol Chem 2004; 279:39303-39309. Inhibition of α-glucosidases I and II increases the cell surface localization of SR-A.
69. Scholz H, Aukrust P, Damas JK, et al. 8-Isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells. Eur J Clin Invest 2004; 34:451-458. 8-Isoprostane increases SR-A activity and foam cell formation.
70. Fukuhara-Takaki K, Saki M, Sakamoto Y, et al. Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo. J Biol Chem 2005; 280:3355-3364. The authors suggest a link between diabetic conditions and atherosclerotic lesion formation due to the increase in SR-A expression by high glucose.
71. Whitman SC, Kuroska EM, Manthey JA, Daugherty A. Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetyl LDL by mouse macrophages. Atherosclerosis 2005; 178:25-32. A citrus flavonoid isolated from tangerines inhibits SR-A and may prevent atherosclerosis at the level of the vascular wall by inhibiting macrophage foam cell formation.
72. Francone OL, Royer L, Boucher G, et al. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotatic factors in Abca1-deficient macrophages. Arterioscler Thromb Vasc Biol 2005; 25: 1-8. In ABCA-1 deficient macrophages SR-A, LOX-1 and CD36 are upregulated, explaining the proatherogenic effect of the absence of leukocyte ABCA-1.
73. Endemann G, Stanton LW, Madden KS, et al. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268:11811-11816.
74. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274:19055-19062.
75. Kunjathoor V, Febbraio M, Podrez EA, et al. Scavenger receptor class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002; 277:49982-49988.
76. Zhao Z, De Beer MC, Cai L, et al. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler Thromb Vasc Biol 2005; 25:168-173. LDL from apoE-deficient mice did induce foam cell formation in a CD36 and SR-A-dependent manner, providing evidence that LDL from apoE-deficient mice can be a substrate for CD36/SR-A.
77. Febbraio M, Podrez EA, Smith JD, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000; 105:1049-1056.
78. Dressman J, Kincer J, Marveev SV, et al. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest 2003; 111:389-397.
79. -/- mice, establishing the essential role of macrophage CD36 in lesion formation.
80. Nagy L, Tontonoz P, Avarez JG, et al. Oxidized LDL regulates macrophages gene expression through ligand activation of PPARγ. Cell 1998; 93:229-240.
81. Nicholson AC, Hajjar DP. CD36, oxidized LDL and PPARy: pathological interactions in macrophages and atherosclerosis. Vasc Pharm 2005; 41:139-146. A nice review on the relation between CD36, oxidized LDL and PPARy activation.
82. Han J, Zhou X, Yokoyama T, et al. Pitavastatin downregulates expression of the macrophage type B scavenger receptor. CD36 Circulation 2004; 109:790-796. The effect of statines on CD36 might explain the additional effects on atherosclerotic lesion formation.
83. Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274:2366-2371.
84. Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20:721-727.
85. Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000; 275:20368-20373.
86. Out R, Hoekstra M, Spijkers JA, et al. Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice. J Lipid Res 2004; 45:2088-2095. This paper shows that SR-BI is the sole molecule responsible for the selective uptake of cholesteryl esters from HDL by the liver.
87. Covey SD, Krieger M, Wang W, et al. Scavenger receptor class B type !-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2003; 23:1589-1594.
88. Trigatti B, Rayburn H, Vinals M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A 1999; 96:9322-9327.
89. Braun A, Trigatti BL, Post MJ, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002; 90:270-276.
90. Karackattu SL, Picard MH, Krieger M. Lymphocytes are not required for the rapid onset of coronary heart disease in scavenger receptor class B type I/apolipoprotein E double 1#knockout mice. Arterioscler Thromb Vasc Biol 2005; 24:1-6. By cross-breeding of SR-BI × apoE double knockout mice with RAG2 mice that lack B and T lymphocytes the authors of this study demonstrate that lymphocytes are not required for the rapid onset of coronary artery disease in SR-BI × apoE double knockout mice.
91. Ji Y, Jian B, Wang N, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272:20982-20985.
92. Chinetti G, Gbaguidi FG, Griglio S, et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxi-some proliferator-activated receptors. Circulation 2000; 101:2411-2417.
93. Hirano K, Yamashita S, Nakagawa Y, et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res 1999; 85:108-116.
94. Van Eck M, Bos IST, Hildebrand RB, et al. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 2004; 165:785-794. This paper describes a unique dual role for SR-BI in bone marrow-derived cells in atherosclerotic lesion development: SR-BI induces the development of small fatty streak lesions, while it protects against the development of more advanced atherosclerotic lesions.
95. Zhang W, Yancey PG, Su YR, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein Å-deficient mice. Circulation 2003; 108:2258-2263.
96. Ramprasad MP, Ficher W, Witztum JL, et al. The 94- to 97-kDa mouse macrophage membrane protein that recognize oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A 1995; 92:9580-9584.
97. De Beer MC, Zhao Z, Webb NR, et al. Lack of a direct role for macrosialin in oxidized LDL metabolism. J Lipid Res 2003; 44:674-685.
98. Llaverias G, Noé V, Penuelas, et al. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem Biophys Res Commun 2004; 318:265-274. The effect of statines on CD68 might explain the additional effects on atherosclerotic lesion formation.
99. Moriwaki H, Kume N, Kataoka T, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha. FEBS Lett 1998; 440:29-32.
100. Kataoka H, Kume N, Miyamoto S, et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999; 99:3110-3117.
101. Tamura Y, Osuga J, Adachi H, et al. Scavenger receptor expressed by endothelial cells I (SREC-I) mediates the uptake of acetylated low density lipoproteins by macrophages stimulated with lipopolysaccharide. J Biol Chem 2004; 279:30938-30944. SREC-I was shown to be responsible for 6% of the degradation of acetylated LDL by macrophages.
102. Wuttge DM, Zhou X, Sheikine Y, et al. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004; 24:750-755.